{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:59:11Z","timestamp":1792659551301,"version":"4.5.0"},"reference-count":16,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>Antiepileptic drugs (AED) may cause body weight changes. OBJECTIVE: To evaluate the dietary habits and body weight associated with AED in epileptic patients. METHOD: Sixty-six patients were subjected to two interviews, and had their weight and body mass index calculated and compared at both times, interval between six to eight months. RESULTS: It was observed that 59.1% showed weight gain. The patients who had no weight gain had a greater proportion of individuals who engaged in some form of physical activity. However, of the 45 patients who maintained their initial dietary and medication pattern, 75.6% recorded a weight gain. Weight gain was seen in 66.7% of patients on carbamazepine (n=18), 60% on valproate (n=5), 50% on carbamazepine+clobazam treatment (n=14), and 58.3% of patients on other(s) polytherapy (n=12). CONCLUSION: The patient should be alerted to possible weight gain, and should be advised about dieting and participating in regular physical activity.<\/jats:p>","DOI":"10.1590\/s0004-282x2010000200024","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T12:52:50Z","timestamp":1273063970000},"page":"277-281","source":"Crossref","is-referenced-by-count":25,"title":["Modification in body weight associated with antiepileptic drugs"],"prefix":"10.1590","volume":"68","author":[{"given":"Camilla N. De","family":"Gaspari","sequence":"first","affiliation":[{"name":"University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.M.","family":"Guerreiro","sequence":"additional","affiliation":[{"name":"University of Campinas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Epilepsia: o paciente otimamente controlado","first-page":"59","volume-title":"Tratamento das epilepsias rec\u00e9m-diagnosticadas","author":"Guerreiro CAM","year":"1999"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00002018-199614050-00005","article-title":"Bodyweight changes as an adverse effect of drug treatment: Mechanisms and management","volume":"14","author":"Pijl H","year":"1996","journal-title":"Drug Saf","ISSN":"https:\/\/id.crossref.org\/issn\/0114-5916","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","article-title":"Bodyweight gain and anticonvulsants: a comparative review","volume":"24","author":"Jallon P","year":"2001","journal-title":"Drug Saf","ISSN":"https:\/\/id.crossref.org\/issn\/0114-5916","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton V","year":"2003","journal-title":"CNS Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/1172-7047","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen V","year":"2002","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref6","series-title":"Obesidade: atualiza\u00e7\u00e3o terap\u00eautica 2007: manual pr\u00e1tico de diagnostic e tratamento","first-page":"332","author":"Prado FC","year":"2007","edition":"23\u00aa"},{"key":"ref7","first-page":"1028","article-title":"Effect of physical activity on cognition in older adults at risk for Alzheimer disease","volume":"300","author":"Lautenschaler Nt","year":"2008","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.300.9.1077","article-title":"Editorial: physical activity for older adults at risk for Alzheimer disease","volume":"300","author":"Larson EB","year":"2008","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref9","first-page":"31","article-title":"Drug-induced weight gain","volume":"28,9","author":"Ness-Abramof R","year":"2005","journal-title":"Timely Top Med Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1600-0404.2005.00506.x","article-title":"Adverse effects of antiepileptic drugs","volume":"181","author":"Perucca E","year":"2005","journal-title":"Acta Neurol Scand","ISSN":"https:\/\/id.crossref.org\/issn\/0001-6314","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.nrl.0000202599.21758.9a","article-title":"Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent","volume":"12","author":"Biton V","year":"2006","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref12","first-page":"507","article-title":"Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management","volume":"31","author":"Ruetsch O","year":"2005","journal-title":"Encephale","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7006","issn-type":"print"},{"key":"ref13","first-page":"329","article-title":"Metabolic effects of AEDs: impact on body weight, lipids and glucose metabolism","volume":"83","author":"Sheth RD","year":"2008","journal-title":"Int Rev Neurobiol","ISSN":"https:\/\/id.crossref.org\/issn\/0074-7742","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann U","year":"2003","journal-title":"J Psychiatr Res","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3956","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1059-1311(97)80065-9","article-title":"Weight gain with valproate or carbamazepine: a reappraisal","volume":"6","author":"Easter D","year":"1997","journal-title":"Seizure","ISSN":"https:\/\/id.crossref.org\/issn\/1059-1311","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.54.4.973","article-title":"Stable weight during lamotrigine therapy: a review of 32 studies","volume":"54","author":"Devinsky O","year":"2000","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v68n2\/24.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T11:34:41Z","timestamp":1495798481000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2010000200024&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0004-282X2010000200024"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2010000200024","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}